News

Press Release / February 2023
Origami Surgical Inc. announces FDA clearance for a label expansion for the insertion and removal of our StitchKit® device through an existing 8mm trocar site incision under direct endoscopic visualization.
Madison, NJ, February 21, 2023 – Origami Surgical has received a new FDA clearance for the insertion and removal of our StitchKit® device.

---

Announcement / December 2022
Origami announces our latest clinical white paper, which compares operative times for a robotic-assisted suture intensive procedure. Two surgeons performed the same procedure, one surgeon utilized the StitchKit® and the other with traditional suturing. The outcome is a time savings of ~30 minutes per case when using StitchKit®. 

---

Announcement / August 2021
Origami Surgical is pleased to announce the FDA clearance for four new suture materials to our StitchKit® technology platform. These new materials give the surgeon additional flexibility when selecting their suture preference when utilizing StitchKit®.

---

Press Release / March 2021
Origami Surgical Inc. announces FDA clearance for its next generation StitchKit^® robotic platform technology with three new products.
Origami Surgical announces the clearance of their newest technology platform which will provide surgeons with additional StitchKit® devices tailored to meet their specific robotic-assisted suturing needs.

---

Press Release / October 2020
Origami Surgical Inc. announces FDA clearance of its newest device, StitchKit^®PARK™
Madison, NJ, October 9, 2020 – Origami Surgical announced that the FDA has cleared StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice.

---

Media

For media inquiries, please email us at info@stitchkit.com.